The same group of researchers suggested that ACCs cells with higher metastasis feature might present greater angiogenic ability and that inhibition of NF-κB signaling, not only suppresses VEGF and iNOS expression but also affects EC mobility in ACC cell lines [44,45]. This evidence concerns the gene NFKB1 and adrenal cortex carcinoma.